Introduction
The breast cancer susceptibility gene, BRCA1, encodes a protein of 1863 amino acids of nuclear phosphoprotein (1) (2) (3) (4) (5) . Mutations in the BRCA1 locus have been found in approximately 40% of familial breast cancers and most of the combined familial breast and ovarian cancers (6, 7) . BRCA1 contains a number of structural motifs responsible for interaction with cellular proteins to regulate diverse biological functions (8, 9) ; transcription control (10) (11) (12) (13) (14) (15) (16) (17) , cell cycle regulation (18, 19) , chromatin remodeling (20) (21) (22) , DNA damage repair (23) (24) (25) (26) and centrosome localization and duplication (27, 28) .
Recent studies have demonstrated that phosphorylation of specific residues of BRCA1 protein, such as Ser988, Ser1423 and Ser1524 etc, is important for regulation of survival of cells with DNA-damage (29) (30) (31) (32) (33) . Of note, phosphorylation of BRCA1 is induced by kinases, including Ataxia Telangiectasia Mutated (ATM), ATR, Chk2 and c-Abl, which are known to be involved in checkpoint machinery. These results indicate that the physiological function of BRCA1 is at least in part determined by phosphorylation of specific residues.
The essential functions of BRCA1 have been further explored by BRCA1-null or exon 11-deleted mice (18, 28, (34) (35) (36) . Analysis of exon 11-deleted MEFs from such mutant mice indicates that compared to normal MEFs, which contains one or two centrosomes, about 25% of mutant MEFs contain more than two, leading to loss of the G2-M checkpoint and aneuploidy (18) . Interestingly, we found that without DNA-damage, Ser988-phosphorylated BRCA1 resides in the centrosome and chromosome through metaphase to telophase as a result of the actions of anti-phospho-specific antibodies that recognize phosphorylated Ser988 of BRCA1 (5) . These results reinforce the working by guest on http://www.jbc.org/ Downloaded from 4 hypothesis that BRCA1 plays an important role in mitosis, but the role of phosphorylation of the protein in regulation of the M phase is largely unknown.
The Aurora-A gene locus is located in the 20q13 chromosome region, which is frequently amplified in several different types of malignant tumors such as breast, colorectal, pancreatic and bladder cancers (37, 38) . In particular, the 20q11-q13 region is amplified in 40% of breast cancer cell lines as well as in 12% to 18% of primary tumors.
The encoded protein, Aurora-A, is a member of the Ser/Thr kinase family, and recent studies have demonstrated that Aurora-A is involved in the G2-M checkpoint and mitosis commitment (39) (40) (41) (42) . In Drosophila, mutations in the aurora-A gene result in incomplete centrosome positioning, leading to abnormal formation of spindle poles and astral microtubules (43, 44) . In Xenopus egg extracts, Eg2, a homologue of Aurora-A, has been shown to be involved in mitotic spindle assembly (45) . Furthermore, recent studies have demonstrated that Aurora-A is inactivated by DNA damage at the end of the G2 phase and over-expression of Aurora-A abrogates the G2 checkpoint in higher eukaryotes (39).
Significantly, Aurora-A is recruited to the centrosome during early G2 and it becomes phosphorylated and activated in centrosomes late in the G2 phase (42) . Moreover, small interfering (si) RNA-mediated depletion of Aurora-A results in the failure to enter mitosis, suggesting that Aurora-A dependent signaling in the centrosome is crucial for mitosis commitment.
On the basis of these observations, we explored whether BRCA1 regulates mitosis entry through functional interaction with Aurora-A in the G2 to M phases. Our results demonstrate that Aurora-A binds to BRCA1 and phosphorylates Ser308 of BRCA1. A phospho-specific antibody recognizing phosphorylated Ser308 showed that this 5 phosphorylation increases in early M phase but is inhibited by IR damage. A biological assay by means of BRCA1 (-/-) MEFs revealed that BRCA1 phosphorylation by Aurora-A might regulate mitotic entry. Given that both Aurora-A and BRCA1 are closely associated with breast carcinogenesis, our results suggest a model in which derailed regulation of G2-M transition by these proteins predisposes to cancer development.
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Experimental Procedures
Cell Culture, Synchronization and Fluorescence-activated Cell Sorter Analysis MCF7, U2OS cells and BRCA1 (-/-) MEFs (46) were maintained in Dulbecco's modified Eagle's medium (DMEM)/10% fetal bovine serum (FBS). For synchronization of the cell cycle at the G1/S boundary, a double-thymidine block and release was performed (47).
Briefly, MCF7 cells were treated with 2.5mM thymidine for 16h and then released by washing them with phosphate-buffered saline (PBS) three times followed by placing them in fresh medium containing DMEM/10% FBS. 
Plasmid Construction and Adenovirus Production
Wild type and kinase-defective forms of Aurora-A have been described previously (49).
BRCA1Ser308Asn was generated using QuickChange (Stratagene) with primers of 5'-TGTAATAAAAACAAACAGCCT-3' and its complement sequence. FLAG-tagged BRCA1 cDNA was subcloned into pBabepuro and retrovirus was generated as described (50) . Both cDNAs were subcloned into a pAdTRACK-CMV vector and recombination was performed in a BJ5180 bacterial strain as reported previously (11 
Transfection, Immunoprecipitation and Immunoblot Analysis
For si-RNA analysis of Aurora-A, double strand RNA (5'-AAAUGCCCUGUCUUACU GUCA-3') was synthesized (Dharmacon) and transfected with OligofectAMINE GST pull-down assay using total cell lysates of MCF7 cells were described previously (10, 11) . Briefly, 500µg of lysates were incubated with about 1µg of GST-fusion proteins for 1h at 4°C. After glutathione beads were added to each sample, samples were further rotated for 1h at 4°C. After extensive washing with NET-N buffer, samples were loaded in 7.5% SDS-PAGE and blotted with anti Aurora-A antibody.
In Vitro Kinase Assay
Immunoprecipitates were washed with NET-N buffer containing 500mM of NaCl followed by kinase buffer (50mM Tris-HCl, pH7.5, 15mM MgCl 2 , 1mM dithiothreitol).
Each sample was incubated with 20µl of kinase buffer containing 5µCi of [γ-
32 P] ATP and 1µg of GST-BRCA1 proteins for 10min at 30 o C and then separated in SDS-PAGE.
Gels were dried and autoradiographed.
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Results
BRCA1 Forms a Complex with Aurora-A
Aurora-A/BTAK/STK15 is a Ser/Thr kinase, which is localized in the centrosome and frequently amplified in human cancer (38) (39) (40) (41) (42) . Recent studies have shown that Aurora-A plays a crucial role in mitotic entry and that Aurora-A activation in the G2-M transition is inhibited by DNA damage (39). Since we and others have found that BRCA1 is also localized in the centrosome (5,27), we examined whether BRCA1 and Aurora-A form a complex in normally growing cells. BRCA1 was immunoprecipitated from unsynchronized BRCA1-mutated HCC1937 or MCF7 cells with anti-BRCA1 antibodies, C-20 and Ab-1 as indicated in Figure 1A . Samples were immunoblotted with antiAurora-A antibody. As shown in Figure 1A , Aurora-A was detected in the BRCA1
immunoprecipitates from MCF7 cells.
We next determined the Aurora-A binding region of BRCA1. BRCA1 aa1-324, aa260-553, aa502-802, aa758-1064, aa1005-1313 and aa1314-1863 were expressed as Nterminal GST fusion proteins in bacteria. After purification, the GST-fusion proteins were incubated with purified Aurora-A protein and samples were extensively washed by NET-N buffer containing 500mM of NaCl as described in Experimental Procedures followed by immunoblotted with anti-Aurora-A antibody. As shown in Figure 1B top, interaction with Aurora-A was detected in aa1314-1863 region. Interestingly, when cell lysates were incubated with six GST-BRCA1 fragments above, both aa758-1064 and aa1314-1863 segments of BRCA1 were found to bind to Aurora-A ( Figure 1B, bottom) .
These results suggest that, although BRCA1 aa1314-1863 is a primary binding region to Aurora-A, BRCA1 aa758-1064 may indirectly bind to Aurora-A through cellular protein(s). GST-BRCA1 fragments were immunoblotted in the separate SDS-PAGE with anti-GST antibody to confirm that similar amounts of GST-fusion proteins were used for this assay ( Figure 1C ).
These results demonstrate that BRCA1 forms a complex with Aurora-A in vivo.
Aurora-A Phosphorylates BRCA1 in vitro
Since both BRCA1 and Aurora-A coexist in the centrosome and form a complex in vivo as shown above, we investigated whether BRCA1 is phosphorylated by Aurora-A. GSTtagged Aurora-A was expressed in 293T cells and affinity-precipitated with GSH (glutathione)-beads. Samples were extensively washed with NET-N buffer containing 500mM of NaCl and divided into six aliquots and an in vitro kinase assay performed using as a substrate the purified GST-fusion proteins of BRCA1 from the experiment shown in Figure 1C . Expression of GST-tagged Aurora-A was confirmed by anti-GST immunoblot analysis after GST-pull down of the protein with GSH beads (Figure 2A ). As shown in Figure 2B , GST-Aurora-A strongly phosphorylated BRCA1 aa260-553 and, less efficiently, the aa1314-1863 segments. To rule out the possibility that an unknown kinase(s) binding to the GST region of GST-Aurora-A phosphorylated the substrates, the same in vitro kinase assay was performed expressing GST protein alone in 293T cells followed by affinity-purification. Since precipitated GST did not phosphorylate BRCA1 segments used in the experiment shown in Figure 2B , phosphorylation of BRCA1 aa260-553 is not carried out by a kinase(s) that binds to the GST tag (data not shown). We confirmed that similar levels of GST-BRCA1 proteins were used as substrates by coomassie blue-staining of a gel ( Figure 2C ). Aurora-A-dependent phosphorylation of 
Aurora-A Phosphorylates Ser308 of BRCA1
Previous studies identified putative consensus phosphorylation sites of Aurora-A using mass spectrometry analysis of 28 kinetochore proteins phosphorylated by Aurora-A (51).
Among these motifs are K{S/T} sequences whose phosphorylation by lpl1p/Aurora-A have been found in Dam1, Spc34 and the autophosphorylation site of lpl1p/Aurora. In BRCA1 aa260-553, five Ser and Thr residues fit this motif (Ser308, Ser444, Ser451, Thr464 and Thr528), and mutagenic analysis (S308N, S444A, S451A, T464A and T528A) revealed that phosphorylation of BRCA1 aa260-553 by Aurora-A is abolished only in S308N mutant ( Figure 3A and data not shown).
We generated rabbit anti-phospho-specific antibody, S308P, which recognizes immediately after they were released from G2 arrest. Cell lysates were prepared at 1h, 2h
and 3h after the cells were released to entry into mitosis. Immunoblot analysis demonstrated that phosphorylation of Ser308 is prominent in the M phase gradually decreased in 2h to 3h after entry into mitosis. Significantly, Ser308 phosphorylation was severely inhibited when cells were exposed to IR damage at the entry into M phase.
It has been shown that both protein levels and kinase activity of Aurora-A increase during the late G2 to M phase (39, 42) . Phosphorylation of Thr288 of Aurora-A, which is located in the T loop of the kinase domain, results in a marked increase in enzymatic activity (52) . Using the cell lysates of Figure 3D , we studied whether Aurora-A activity is downregulated in IR-treated cells ( Figure 3E) . Consistent with previous studies, protein levels of Aurora-A significantly increased in M phase. Phosphorylation of Thr288 also increased in the M phase, suggesting that kinase activity also increased in this phase.
Under IR damage, phosphorylation of Thr288 was severely inhibited, whereas increase in protein level was weakly decreased. Taken together, these results demonstrate that Aurora-A phosphorylates Ser308 of BRCA1 when cells enter mitosis, and this phosphorylation is inhibited under DNA damage as a result of inhibition of Aurora-A activation.
Decreasing Aurora-A Protein by si-RNA Results in Reduced Ser308
Phosphorylation Aurora-A-dependent phosphorylation of Ser308 of BRCA1 was further investigated by decreasing the endogenous protein levels of Aurora-A with small interfering (si)-RNA.
We used human osteosarcoma cell line U2OS because these cells are highly transfectable. U2OS cells were transfected with synthesized double strand RNA specific for the Aurora-A sequence. After 18h, cell lysates were immunoblotted as indicated in Figure 4A . Decreased levels of Aurora-A protein levels did not affect the levels of BRCA1 protein, but phosphorylation of Ser308 was markedly reduced in Aurora-A knock-down cells. These results reinforce the hypothesis that Aurora-A phosphorylates Ser308 of BRCA1 in vivo.
Transient Expression of Aurora-A, but Not the Kinase-Defective Form, Induces
Ser308 Phosphorylation
We generated recombinant adenovirus expressing wild type-or kinase-defective (KD, 
BRCA1 Ser308 Phosphorylation by Aurora-A Influences G2 to M Progression
The results presented thus far demonstrate that BRCA1 becomes phosphorylated by Aurora-A when cells enter mitosis. We explored the role of Ser308 phosphorylation in Biochemical analyses have identified several motifs that can be phosphorylated by Aurora-A (51,54). Among them are the K{S,T} motif, whose phosphorylation by Aurora-A was detected in Dam1, Spc34 and the lpl1p/Aurora autophosphorylation site and was confirmed in vivo by mass spectrometry (50). We identified Ser308 as a major phosphorylation site of the BRCA1 aa260-553 region by Aurora-A, which is efficiently phosphorylated by an in vitro kinase assay. Since this region of BRCA1 contains five Ser/Thr residues that fit this motif (Ser308, Ser444, Ser451, Thr464 and Thr528), optimal phosphorylation of Ser308 is probably determined by the adjacent amino acid sequence.
It has been shown that MEFs carrying mutant alleles of BRCA1 contain more than two centrosomes compared to normal MEFs containing one or two. Also, centrosome maturation from the late S to the M phase is critical for completion of mitosis (56) . One may speculate that immature chromosome segregation due to lack of functional 18 centrosomes causes multinucleation and multicentrosomes, which are the hallmark of cancer cells. Identification of proteins that cooperate with BRCA1 in mitosis needs to be extended to further understand the mechanism by which loss of BRCA1 establishes a predisposition to cancer. by guest on November 6, 2017
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